BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens

Eun Mi Hwang, Young Bae Ryu, Hoi Young Kim, Dong Gyu Kim, Seong Geun Hong, Jin Hwan Lee, Marcus J. Curtis-Long, Seong Hun Jeong, Jae-Yong Park, Ki Hun Park

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

In order to access β-secretase (BACE1), and enzyme strongly implicated in the cause of Alzheimer's disease, inhibitors must possess sufficient lipophilicity to traverse two lipid bilayers. Current drug candidates, which are almost totally peptide-derived, are thus inefficient because cell permeability presents a serious limiting factor. In this study, lipophilic alkylated (C 10 -C 5 ) flavanones from Sophora flavescens were examined for their inhibitory effects against β-secretase. Lavandulyl flavanones (1, 2, 5, 6, and 8) showed potent β-secretase inhibitory activities with IC 50 s of 5.2, 3.3, 8.4, 2.6, and 6.7 μM, respectively, while no significant activity was observed in the corresponding hydrated lavandulyl flavanones (4 and 7) and prenylated flavanone (3). As we expected, lavandulyl flavanones reduced Aβ secretion dose-dependently in transfected human embryonic kidney (HEK-293) cells. In kinetic studies, all compounds screened were shown to be noncompetitive inhibitor.

Original languageEnglish
Pages (from-to)6669-6674
Number of pages6
JournalBioorganic and Medicinal Chemistry
Volume16
Issue number14
DOIs
Publication statusPublished - 2008 Jul 15
Externally publishedYes

Fingerprint

Sophora
Flavanones
Amyloid Precursor Protein Secretases
Lipid bilayers
HEK293 Cells
Lipid Bilayers
Permeability
Alzheimer Disease
Kidney
Peptides
Kinetics
Enzymes
Pharmaceutical Preparations

Keywords

  • Alzheimer's disease
  • BACE1
  • HEK 293
  • Lavandulyl flavanone
  • Sophora flavescens

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Hwang, E. M., Ryu, Y. B., Kim, H. Y., Kim, D. G., Hong, S. G., Lee, J. H., ... Park, K. H. (2008). BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens. Bioorganic and Medicinal Chemistry, 16(14), 6669-6674. https://doi.org/10.1016/j.bmc.2008.05.080

BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens. / Hwang, Eun Mi; Ryu, Young Bae; Kim, Hoi Young; Kim, Dong Gyu; Hong, Seong Geun; Lee, Jin Hwan; Curtis-Long, Marcus J.; Jeong, Seong Hun; Park, Jae-Yong; Park, Ki Hun.

In: Bioorganic and Medicinal Chemistry, Vol. 16, No. 14, 15.07.2008, p. 6669-6674.

Research output: Contribution to journalArticle

Hwang, EM, Ryu, YB, Kim, HY, Kim, DG, Hong, SG, Lee, JH, Curtis-Long, MJ, Jeong, SH, Park, J-Y & Park, KH 2008, 'BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens', Bioorganic and Medicinal Chemistry, vol. 16, no. 14, pp. 6669-6674. https://doi.org/10.1016/j.bmc.2008.05.080
Hwang, Eun Mi ; Ryu, Young Bae ; Kim, Hoi Young ; Kim, Dong Gyu ; Hong, Seong Geun ; Lee, Jin Hwan ; Curtis-Long, Marcus J. ; Jeong, Seong Hun ; Park, Jae-Yong ; Park, Ki Hun. / BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens. In: Bioorganic and Medicinal Chemistry. 2008 ; Vol. 16, No. 14. pp. 6669-6674.
@article{efb5f1e05b924369bebfe075174583bb,
title = "BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens",
abstract = "In order to access β-secretase (BACE1), and enzyme strongly implicated in the cause of Alzheimer's disease, inhibitors must possess sufficient lipophilicity to traverse two lipid bilayers. Current drug candidates, which are almost totally peptide-derived, are thus inefficient because cell permeability presents a serious limiting factor. In this study, lipophilic alkylated (C 10 -C 5 ) flavanones from Sophora flavescens were examined for their inhibitory effects against β-secretase. Lavandulyl flavanones (1, 2, 5, 6, and 8) showed potent β-secretase inhibitory activities with IC 50 s of 5.2, 3.3, 8.4, 2.6, and 6.7 μM, respectively, while no significant activity was observed in the corresponding hydrated lavandulyl flavanones (4 and 7) and prenylated flavanone (3). As we expected, lavandulyl flavanones reduced Aβ secretion dose-dependently in transfected human embryonic kidney (HEK-293) cells. In kinetic studies, all compounds screened were shown to be noncompetitive inhibitor.",
keywords = "Alzheimer's disease, BACE1, HEK 293, Lavandulyl flavanone, Sophora flavescens",
author = "Hwang, {Eun Mi} and Ryu, {Young Bae} and Kim, {Hoi Young} and Kim, {Dong Gyu} and Hong, {Seong Geun} and Lee, {Jin Hwan} and Curtis-Long, {Marcus J.} and Jeong, {Seong Hun} and Jae-Yong Park and Park, {Ki Hun}",
year = "2008",
month = "7",
day = "15",
doi = "10.1016/j.bmc.2008.05.080",
language = "English",
volume = "16",
pages = "6669--6674",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "14",

}

TY - JOUR

T1 - BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens

AU - Hwang, Eun Mi

AU - Ryu, Young Bae

AU - Kim, Hoi Young

AU - Kim, Dong Gyu

AU - Hong, Seong Geun

AU - Lee, Jin Hwan

AU - Curtis-Long, Marcus J.

AU - Jeong, Seong Hun

AU - Park, Jae-Yong

AU - Park, Ki Hun

PY - 2008/7/15

Y1 - 2008/7/15

N2 - In order to access β-secretase (BACE1), and enzyme strongly implicated in the cause of Alzheimer's disease, inhibitors must possess sufficient lipophilicity to traverse two lipid bilayers. Current drug candidates, which are almost totally peptide-derived, are thus inefficient because cell permeability presents a serious limiting factor. In this study, lipophilic alkylated (C 10 -C 5 ) flavanones from Sophora flavescens were examined for their inhibitory effects against β-secretase. Lavandulyl flavanones (1, 2, 5, 6, and 8) showed potent β-secretase inhibitory activities with IC 50 s of 5.2, 3.3, 8.4, 2.6, and 6.7 μM, respectively, while no significant activity was observed in the corresponding hydrated lavandulyl flavanones (4 and 7) and prenylated flavanone (3). As we expected, lavandulyl flavanones reduced Aβ secretion dose-dependently in transfected human embryonic kidney (HEK-293) cells. In kinetic studies, all compounds screened were shown to be noncompetitive inhibitor.

AB - In order to access β-secretase (BACE1), and enzyme strongly implicated in the cause of Alzheimer's disease, inhibitors must possess sufficient lipophilicity to traverse two lipid bilayers. Current drug candidates, which are almost totally peptide-derived, are thus inefficient because cell permeability presents a serious limiting factor. In this study, lipophilic alkylated (C 10 -C 5 ) flavanones from Sophora flavescens were examined for their inhibitory effects against β-secretase. Lavandulyl flavanones (1, 2, 5, 6, and 8) showed potent β-secretase inhibitory activities with IC 50 s of 5.2, 3.3, 8.4, 2.6, and 6.7 μM, respectively, while no significant activity was observed in the corresponding hydrated lavandulyl flavanones (4 and 7) and prenylated flavanone (3). As we expected, lavandulyl flavanones reduced Aβ secretion dose-dependently in transfected human embryonic kidney (HEK-293) cells. In kinetic studies, all compounds screened were shown to be noncompetitive inhibitor.

KW - Alzheimer's disease

KW - BACE1

KW - HEK 293

KW - Lavandulyl flavanone

KW - Sophora flavescens

UR - http://www.scopus.com/inward/record.url?scp=47549114037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47549114037&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2008.05.080

DO - 10.1016/j.bmc.2008.05.080

M3 - Article

VL - 16

SP - 6669

EP - 6674

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 14

ER -